바이오젠(주)
MX ˙ BMV ˙ US09062X1037
SecurityMX:BIIB / Biogen Inc.
InstitutionPoint72 Asset Management, L.P.
ManagerSteven Cohen
Latest Disclosed Ownership809,617 shares
Latest Disclosed Value $ 148,427,085
Point72 Asset Management, L.P. ownership in BIIB / Biogen Inc.

On May 15, 2026 - Point72 Asset Management, L.P. filed a 13F-HR form disclosing ownership of 809,617 shares of Biogen Inc. (MX:BIIB) valued at $148,427,085 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,813,192 shares of Biogen Inc.. This represents a change in shares of -71.22% during the quarter.

Point72 Asset Management, L.P. has a history of taking positions in derivatives of the underlying security (BIIB) in the form of stock options. The firm currently holds call options representing 4,700 of underlying shares valued at $861,651 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:BIIB / Biogen Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOGEN COM 09062X103 809,617 -2,003,575 -71.22 148,427 -70.02 0.1902
2026-02-17 2025-12-31 13F BIOGEN COM 09062X103 2,813,192 -1,059,709 -27.36 495,094 -8.74 0.5537
2025-11-14 2025-09-30 13F BIOGEN COM 09062X103 3,872,901 41,174 1.07 542,516 12.74 0.9079
2025-08-14 2025-06-30 13F BIOGEN COM 09062X103 3,831,727 3,424,470 840.86 481,227 763.51 0.9447
2025-07-21 2025-03-31 13F/A-1 BIOGEN COM 09062X103 407,257 407,257 55,729 0.1272
2025-05-15 2025-03-31 13F BIOGEN COM 09062X103 407,257 407,257 55,729 0.1272
2024-02-14 2023-12-31 13F BIOGEN COM 09062X103 0 -48,100 -100.00 0 -100.00
2023-11-14 2023-09-30 13F BIOGEN COM 09062X103 48,100 -577,541 -92.31 12,362 -93.06 0.0361
2023-08-14 2023-06-30 13F BIOGEN COM 09062X103 625,641 -69,472 -9.99 178,214 -7.79 0.5300
2023-05-15 2023-03-31 13F BIOGEN COM 09062X103 695,113 -531,011 -43.31 193,262 -43.08 0.5986
2023-05-15 2022-12-31 13F/A-1 BIOGEN COM 09062X103 1,226,124 -451,858 -26.93 339,538 -24.21 1.1540
2023-02-14 2022-12-31 13F BIOGEN COM 09062X103 1,226,124 -451,858 339,538 1.1540
2022-11-14 2022-09-30 13F BIOGEN COM 09062X103 1,677,982 1,222,182 268.14 448,021 381.97 1.7894
2022-08-15 2022-06-30 13F BIOGEN COM 09062X103 455,800 360,000 375.78 92,956 360.75 0.3922
2022-05-16 2022-03-31 13F BIOGEN COM 09062X103 95,800 -515,700 -84.33 20,175 -86.25 0.0801
2022-02-14 2021-12-31 13F BIOGEN COM 09062X103 611,500 580,648 1,882.04 146,711 1,580.35 0.5859
2021-11-15 2021-09-30 13F BIOGEN COM 09062X103 30,852 -214,654 -87.43 8,731 -89.73 0.0383
2021-08-16 2021-06-30 13F BIOGEN COM 09062X103 245,506 130,106 112.74 85,011 163.33 0.3820
2021-05-17 2021-03-31 13F BIOGEN COM 09062X103 115,400 -83,360 -41.94 32,283 -33.67 0.1508
2021-02-16 2020-12-31 13F BIOGEN COM 09062X103 198,760 82,817 71.43 48,668 47.97 0.2374
2020-11-16 2020-09-30 13F BIOGEN COM 09062X103 115,943 115,943 32,891 0.1684
2020-05-15 2020-03-31 13F BIOGEN COM 09062X103 0 -54,081 -100.00 0 -100.00
2020-02-14 2019-12-31 13F BIOGEN COM 09062X103 54,081 54,081 16,047 0.0844
2019-05-15 2019-03-31 13F BIOGEN COM 09062X103 0 -35,000 -100.00 0 -100.00
2019-02-14 2018-12-31 13F BIOGEN COM 09062X103 35,000 -7,500 -17.65 10,532 -29.86 0.0514
2018-11-14 2018-09-30 13F BIOGEN COM 09062X103 42,500 -103,500 -70.89 15,016 -64.56 0.0619
2018-08-14 2018-06-30 13F BIOGEN COM 09062X103 146,000 -298,615 -67.16 42,375 -65.19 0.1691
2018-05-15 2018-03-31 13F BIOGEN COM 09062X103 444,615 192,296 76.21 121,744 51.46 0.5089
2018-02-14 2017-12-31 13F BIOGEN COM 09062X103 252,319 -255,603 -50.32 80,381 -49.46 0.3470
2017-11-14 2017-09-30 13F BIOGEN COM 09062X103 507,922 -384,179 -43.06 159,041 -34.30 0.7098
2017-08-14 2017-06-30 13F BIOGEN COM 09062X103 892,101 675,631 312.11 242,081 309.01 1.3581
2017-05-15 2017-03-31 13F BIOGEN COM 09062X103 216,470 162,928 304.30 59,187 289.82 0.3299
2017-02-14 2016-12-31 13F BIOGEN COM 09062X103 53,542 -64,006 -54.45 15,183 -58.74 0.1062
2016-11-14 2016-09-30 13F BIOGEN COM 09062X103 117,548 117,548 0.00 36,796 0.2587
2016-08-15 2016-06-30 13F BIOGEN COM 09062X103 0 -102,200 -100.00 0 -100.00
2016-05-16 2016-03-31 13F BIOGEN COM 09062X103 102,200 15,500 17.88 26,605 0.17 0.2041
2016-02-16 2015-12-31 13F BIOGEN COM 09062X103 86,700 79,900 1,175.00 26,561 1,238.76 0.2191
2015-11-16 2015-09-30 13F BIOGEN COM 09062X103 6,800 6,800 0.00 1,984 0.0156
2015-08-14 2015-06-30 13F BIOGEN COM 09062X103 0 -8,800 -100.00 0 -100.00
2015-05-15 2015-03-31 13F BIOGEN COM 09062X103 8,800 8,800 0.00 3,716 0.0253
2014-11-14 2014-09-30 13F BIOGEN IDEC COM 09062X103 0 -7,600 -100.00 0 -100.00
2014-08-14 2014-06-30 13F BIOGEN IDEC COM 09062X103 7,600 7,600 2,396 0.0154
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BIOGEN COM Call 4,700 -99.53 862 -99.51 n/a n/a n/a
2026-02-17 2025-12-31 13F BIOGEN COM Call 1,001,500 0.15 176,254 25.82 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOGEN COM Call 1,000,000 300.00 140,080 346.16 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOGEN COM Call 250,000 31,398 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOGEN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOGEN COM Call 10,000 2,399 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOGEN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOGEN COM Call 69,600 22,020 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.